
GeneDx Faces Class Action Over Alleged Securities Fraud
Investors who purchased GeneDx Holdings Corp. securities between April 16, 2025, and May 4, 2026, are being urged to join a class action lawsuit led by The Schall Law Firm. The litigation centers on claims that the company misled the market regarding its financial health during the specified period.






















